Ankündigung • Sep 30
Innovative MedTech, Inc. announced delayed annual 10-K filing On 09/29/2025, Innovative MedTech, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. Ankündigung • May 16
Innovative MedTech, Inc. announced delayed 10-Q filing On 05/15/2025, Innovative MedTech, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Ankündigung • Feb 15
Innovative MedTech, Inc. announced delayed 10-Q filing On 02/14/2025, Innovative MedTech, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Ankündigung • Dec 21
Innovative MedTech, Inc. has filed a Follow-on Equity Offering in the amount of $3.2 million. Innovative MedTech, Inc. has filed a Follow-on Equity Offering in the amount of $3.2 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 16,000,000
Price\Range: $0.05 to $0.2
Discount Per Security: $0.016 Ankündigung • Nov 13
Innovative MedTech, Inc. announced delayed 10-Q filing On 11/12/2024, Innovative MedTech, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Ankündigung • Oct 01
Innovative MedTech, Inc. announced delayed annual 10-K filing On 09/30/2024, Innovative MedTech, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. Ankündigung • May 17
Innovative MedTech, Inc. announced delayed 10-Q filing On 05/15/2024, Innovative MedTech, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Ankündigung • Feb 15
Innovative MedTech, Inc. announced delayed 10-Q filing On 02/14/2024, Innovative MedTech, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Ankündigung • Nov 14
Innovative MedTech, Inc. announced delayed 10-Q filing On 11/13/2023, Innovative MedTech, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Ankündigung • May 18
Innovative MedTech Announces Formation of Scientific Advisory Board and Appoints Roscoe Moore as Member of the Scientific Advisory Board Innovative MedTech, Inc. announced the formation of its new scientific advisory board (‘SAB’), which the company anticipates will be comprised of leading experts in healthcare and gerontology. The first member of the company's SAB will be Dr. Roscoe Moore DVM, M.P.H., Ph.D. (‘Dr. Moore’). The Scientific Advisory Board (‘SAB’) is expected to play a crucial role in providing strategic guidance and scientific expertise to the Company as it seeks to provide the quality of care and to expand its services. The SAB will be responsible for reviewing and evaluating scientific research and best practices related to adult day care, identifying emerging trends and opportunities, assist the Company with a legislative agenda and develop strategies and recommendations to expand and improve the quality of care provided by the Company. Dr. Moore served as an Epidemic Intelligence Service Officer with the Centers for Disease Control and Prevention (CDC), and as an Assistant United States Surgeon General under three Presidential Administrations, and served as the U.S. Chief Veterinary Medical Officer appointed by former U.S. Surgeon General C. Everett Koop. He has also served as a Senior Epidemiologist for the United States Department of Health and Human Services (HHS), and as the Chief Medical Officer of the United States Department of Agriculture's (USDA) Food Safety and Inspection Service. Dr. Moore served in the Office of the US Secretary of Health and Human Services, held the position of Associate Director for Development Support and African Affairs for the Department of Health and Human Services (HHS), and served as the chief epidemiologist with the Centers of Devices and Radiological Health in the US Food and Drug Administration (FDA). Dr. Moore is the Founder and President of PH Rockwood LLC. Dr. Moore has a Ph.D. in Epidemiology from The Johns Hopkins University, an M.P.H. in Epidemiology from the University of Michigan, and a Doctor of Veterinary Medicine and a B.S. degree from Tuskegee Institute; he also has received an honorary D.Sc. degree from Tuskegee University in recognition of his distinguished public health career. Dr. Moore has written or co-authored over 100 publications covering a broad range of public health issues. Dr. Moore serves on the Scientific Advisory Board Member of Immgenuity, Inc., Napo Pharmaceuticals, Arev Life Sciences Global Corp, A Legacy Genetics, and Cera Products Incorporated, as well as being a member of the Board of Directors of OyaGen, Inc., a Senior Fellow at Potomac Institute for Policy Studies, and a Board of Advisor Member of the Institute of Human Virology at the University of Maryland School of Medicine. Ankündigung • Feb 15
Innovative MedTech, Inc. announced delayed 10-Q filing On 02/14/2023, Innovative MedTech, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Ankündigung • Nov 15
Innovative MedTech Inc. announced delayed 10-Q filing On 11/14/2022, Innovative MedTech Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Ankündigung • Sep 28
Innovative MedTech Inc. announced delayed annual 10-K filing On 09/27/2022, Innovative MedTech Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. Ankündigung • Jun 16
Innovative MedTech Announces Live Version of its RX Vitality App Now Available for Public Download in the Apple iOS App Store Innovative MedTech Inc. announced that its RX Vitality digital healthcare wallet is now available for download at the Apple iOS App store for Apple iPhone users. The company’s app has already been approved and is available on the Google Play Store. The company is committed to help bank the underbanked, and to help those who need the benefits of its RX Vitality digital wallet. Some of its key app features for qualified members who sign up and are approved for its RX Vitality digital wallet (which will include a healthcare debit card) include: Shop & Earn store, with discounts at 500+ online merchants; Loyalty Program where members can earn points when they shop and use their wallet (or debit card); Certain pharmaceutical discounts of up to 20% to 75% at 65,000 pharmacies across the United States, including Walgreens and CVS. Ankündigung • Jun 02
Innovative Medtech Appoints Merle Griff as Chief Executive Officer Innovative MedTech Inc. announced that its Board of Directors has appointed Dr. Merle Griff, who is currently the Chief Executive Officer of the Company’s SarahCare subsidiary, as the Company’s new Chief Executive Officer. She will succeed Michael Friedman, who will remain President of the Company and a member of its Board of Directors. Dr. Griff is a highly respected CEO and industry veteran with 35+ years of leadership experience, including founding and managing SarahCare, the Company’s wholly owned subsidiary. Dr. Griff, is the Founder and CEO of SarahCare Senior Solutions, and is one of the leading authorities on the care of seniors in the United States. Dr. Griff has served on numerous national boards and task forces including being the past Chairperson of the Board of Directors for NADSA (National Adult Day Services Association), member of the International Advisory Board for CARF (Commission on the Accreditation for Rehabilitation Facilities) and a task force member for the study of adult day care in the US for the Assistant Secretary of Program and Evaluation in the Department of Aging. Ankündigung • May 28
Innovative MedTech Inc. Announces Chief Executive Officer Change On May 24, 2022, Michael Friedman resigned as the Chief Executive Officer of Innovative MedTec Inc. (the Company), and the Board of Directors of the Company appointed Merle Griff, Ph.D. the Chief Executive Officer of the Company. Mr. Friedman will remain the President of the Company as well as member of the Company's Board of Directors. Merle Griff, Ph.D., age 73, is the Founder and has been the CEO of SarahCare (a wholly owned subsidiary of the Company) since its inception approximately 35 years ago. Ankündigung • May 17
Innovative MedTech Inc. announced delayed 10-Q filing On 05/16/2022, Innovative MedTech Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Ankündigung • May 12
Innovative MedTech Inc. Announces Appointment of David Webb to Company's Advisory Board Innovative MedTech Inc. announced the appointment of David Webb to the Company’s external advisory board to provide advice and guidance to facilitate growth and innovation at the Company. David has been entertaining and informing the public for more than three decades, from music to talk radio, in Boston, Houston, Dallas, New York City, syndication, now satellite radio and television. Currently, David hosts “The David Webb Show” on SiriusXM Patriot 125 with breaking news, analysis, and commentary. Ankündigung • May 06
Innovative MedTech Inc. Appoints Bruce Mcdermott to the Company’s External Advisory Board Innovative MedTech Inc. announced the appointment of Bruce McDermott to the Company’s external advisory board (the “Board”) to provide advice and guidance to facilitate growth and innovation at the Company. Mr. McDermott was one of the sellers of RX Vitality Inc., which the Company acquired on or about April 28, 2022. Mr. McDermott has nearly 40 years of investment and private banking experience originating and financing new opportunities. Mr. McDermott spent most of his career at Deutsche Bank and predecessor companies Bankers Trust and Alex, Brown & Sons. Mr. McDermott led Product Management and Solutions for the Deutsche Bank Private Wealth Management in the Americas. Ankündigung • Feb 15
Innovative MedTech, Inc. announced delayed 10-Q filing On 02/14/2022, Innovative MedTech, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Ankündigung • Sep 29
Innovative MedTech Inc. announced delayed annual 10-K filing On 09/27/2021, Innovative MedTech Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. 
